Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease. (Q51032319)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 April 2013

Language	Label	Description	Also known as
English	Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease.	scientific article published on 29 April 2013

Statements

scholarly article

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease. (English)

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

author name string

Chizuko Kitabayashi

1

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

Takahiko Naruko

2

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

Kenichi Sugioka

3

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

Kei Yunoki

4

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

Masashi Nakagawa

5

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

Mayumi Inaba

6

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

Masahiko Ohsawa

7

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

Yoshio Konishi

8

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

Masahito Imanishi

9

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

Takeshi Inoue

10

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

Hiroyuki Itabe

11

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

Minoru Yoshiyama

12

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

Kazuo Haze

13

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

Anton E Becker

14

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

Makiko Ueda

15

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

publication date

29 April 2013

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

Hemodialysis International

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

17

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

557-567

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

4

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads.

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem.

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Oxidative stress in end-stage renal disease: an emerging threat to patient outcome

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Oxidative stress in uremia

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Low density lipoprotein oxidation and its pathobiological significance

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myo

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Measurement of plasma oxidized low-density lipoprotein and its clinical implications

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis.

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Prognostic value of myeloperoxidase in patients with chest pain

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Inflammation and cardiovascular risk in dialysis patients.

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients.

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Myeloperoxidase, a leukocyte-derived vascular NO oxidase

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Erythrocyte-rich thrombus aspirated from patients with ST-elevation myocardial infarction: association with oxidative stress and its impact on myocardial reperfusion.

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Minimally Modified LDL Is an Oxidized LDL Enriched with Oxidized Phosphatidylcholines

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Oxidative cross-linking of ApoB100 and hemoglobin results in low density lipoprotein modification in blood. Relevance to atherogenesis caused by hemodialysis.

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

The inflammatory properties of electronegative low-density lipoprotein from type 1 diabetic patients are related to increased platelet-activating factor acetylhydrolase activity.

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Serum Myeloperoxidase and Mortality in Maintenance Hemodialysis Patients

1 reference

https://api.crossref.org/works/10.1111%2FHDI.12049

21 January 2018

Identifiers

10.1111/HDI.12049

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

1 reference

Europe PubMed Central

27 March 2018

http://europepmc.org/abstract/MED/23627905

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51032319&oldid=803365759"